Actisal Tablet 2 mg

Actisal Tablet is a respiratory medication containing Levosalbutamol (2 mg) as its active ingredient. Manufactured by Silva Pharmaceuticals Ltd, this tablet formulation is prescribed for managing bronchospasm and reversible obstructive airway diseases in adults and children aged 6+. Priced at ৳1.71 per unit, it offers cost-effective relief with 10×10 strip packs available for ৳171.

The drug works as a selective β2-adrenoceptor stimulant, providing superior bronchodilation compared to racemic salbutamol. Its optimized formulation minimizes side effects while ensuring rapid airway relaxation. Patients should follow dosage guidelines: 1-2 mg thrice daily for ages 12+, and 1 mg for children (6-11 years). Always consult physicians for personalized regimens.

Common side effects of Actisal Tablet include hypokalemia, tremors, and gastrointestinal discomfort. Storage requires keeping tablets in cool, dry areas away from light. Pregnant/nursing women should use it cautiously after medical consultation. For overdose management, gastric lavage and β-blockers (with caution) are recommended.

This medication interacts with other adrenergic drugs, requiring careful monitoring. Explore Levosalbutamol alternatives under medical supervision if needed. With proper usage, Actisal Tablet remains a trusted choice in Bangladesh’s respiratory care market.

Tablet:
Adults: 1-2 mg three times daily
Children (6-11 years): 1 mg TDS
Syrup:
Adults: 5-10 ml TDS
Children: 5 ml TDS. Duration depends on disease severity, typically until symptom resolution.

Hypocalcaemia, palpitation, fine tremors of the skeletal muscle and muscle cramps may occur. The other likely side effects are nausea, vomiting, burning substernal or epigastric pain and diarrhoea.

Pregnancy Category C: Risk cannot be ruled out. Lactation: Caution advised – monitor infant for tachycardia or irritability if used during breastfeeding.

Monitor blood glucose in diabetics. ECG monitoring essential in hyperthyroid or cardiac patients. Severe asthma attacks may require supplemental therapy.

Start with lower doses in geriatric patients. No dose adjustment needed in hepatic/renal impairment, but monitor potassium in renal failure.

The expected symptoms with over dosage are those of excessive beta-adrenergic stimulation and the symptoms listed under side effects. In the event of serious poisoning, the stomach should be emptied and, if necessary, a beta-blocker administered with caution in patients with a history of bronchospasm.